期刊文献+

不同检测方法对低水平乙型肝炎表面抗原的测定及其临床评估 被引量:4

Evaluation of different methods in determination of low level HBsAg
下载PDF
导出
摘要 目的:探讨免疫发光、电化学免疫发光、ELISA三种方法对检测低水平乙型肝炎表面抗原的价值。方法:以免疫发光测试系统Architect i2000检测结果为参考,把70例<50 IU/ml的标本分成三个级别:<1 ng/ml、1~5 ng/ml、≥5 ng/ml三组,用电化学免疫发光MODULAR〈E〉170、ELISA检测,对三种方法测定的结果进行比较。结果:免疫发光Architect i2000与电化学免疫发光MODULAR〈E〉170比较,<1 ng/ml组符合率79.2%(P(0.05),1~5 ng/ml组符合率100%,≥5ng/ml组符合率100%。免疫发光Architect i2000与ELISA比较,<1 ng/ml组符合率0%,1~5 ng/ml组符合率45.5%(P<0.05),≥5 ng/ml组符合率100%。结论:免疫发光Architect i2000与电化学免疫发光MODULAR〈E〉170对低水平HBsAg的检测效能基本一致,结果相对可靠,常规ELISA法对≥5 ng/ml的HBsAg检测结果可靠,但对低水平HBsAg漏检率高,特别是<1 ng/ml HBsAg很难检出。 Objective:To evaluate chemiluminescent immunoassay(CLIA),electrochemiluminescent immunoassay(ECLIA) and ELISA in determination of low level HBsAg.Methods:According to the standard of CLIA Architect i2000,70 samples were divided into three groups by HBsAg concentration :﹤1 ng/ml,1-5 ng/ml and ≥5 ng/ml.The samples were also determined by ECLIA MODULARE170 and ELISA,and the results were compared with those measured by CLIA Architect i2000.Results:The concordance rates of ECLIA MODULARE170 with Architect i2000 was 79.2% for﹤1 ng/ml group,100% for 1-5 ng/ml group,100% for ≥5 ng/ml group.And the concordance rates of ELISA with Architect i2000 was 0% for﹤1 ng/ml group,45.5% for 1-5 ng/ml group and 100% for ≥5 ng/ml group.Conclusion:For determination of low level HBsAg,CLIA Architect i2000 and ECLIA MODULARE170 have high credibility.ELISA is also credible when HBsAg ≥5 ng/ml,but not for low level HBsAg,especially for HBsAg﹤1 ng/ml.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2011年第4期436-439,共4页 Journal of Zhejiang University(Medical Sciences)
关键词 肝炎表面抗原 乙型/分析 酶联免疫吸附测定/方法 乙型肝炎表面抗原 免疫发光测定 电化学免疫发光测定 ELISA Hepatitis B surface antigens/anal Enzyme-linked immunosorbent assay/methods Hepatitis B surface antigen(HBsAg) Chemiluminescent immunoassay(CLIA) Electrochemiluminescent immunoassay(ECLIA) ELISA
  • 相关文献

参考文献7

二级参考文献28

  • 1邓巍,王露楠,李金明.丙型肝炎病毒抗体酶联免疫吸附试验阳性判断值在献血员血液筛检中的意义[J].中华检验医学杂志,2004,27(10):663-665. 被引量:16
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3侯金林,骆抗先,梁炽森,王战会.HBsAg阴性乙型肝炎病毒感染与S基因插入变异的关系[J].中华传染病杂志,1996,14(3):129-133. 被引量:41
  • 4李金明.感染性疾病血清学检验中应重视对弱反应性标本的确认[J].中华检验医学杂志,2006,29(7):577-580. 被引量:126
  • 5陆志檬 叶维法 钟振义.乙型肝炎的病原诊断[A].叶维法,钟振义.肝病免疫学[C].天津:天津科学技术出版社,1997.283-286.
  • 6Gall D,Nielsen K.Comparison of some methods for determing cutoff values for serological assays:a retrospective study using the fluorescence polarization assay[J].J Immunoassay Immunochem,2001,22(1):85-98.
  • 7Resat O,Fehmi T,Veysel T,et al.Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment[J].Digest Dis Sci,2008,53(11):2995-2998.
  • 8Lai CL,Yuen MF.The natural history of chronic hepatitis B[J].J Viral Hepatitis,2007,14(1):6-10.
  • 9O.Lada,Y.Benhamou,T.Poynard,et al.Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers:influence of "a" determinant Variants[J].J Virol,2006,80(6):2968-2975.
  • 10Gall D, Nielsen K. Comparison of some methods for determing cutoff values for serological assays: a retrospective study using the fluorescence polarization assay. J Immunoassay Immunochem,2001,22 : 85-98.

共引文献282

同被引文献34

  • 1常杏红,姚丽英.医务人员HBV和HCV感染情况分析[J].实用医技杂志,2006,13(5):668-669. 被引量:3
  • 2邓梅英,阳彦芹,陈宇,黄巧莉,唐玉杰,王锦恒,粟明丽.输血前和手术前患者血液检测结果分析及其重要性[J].华夏医学,2006,19(1):121-123. 被引量:6
  • 3强来英,张桂云,王慜杰,蒋岩,邵一鸣.我国HIV职业暴露的危险性分析[J].中国输血杂志,2006,19(6):449-451. 被引量:29
  • 4Chan HL,Thompson A, Martinot-Peiqnoux M, et al. Hepatitis B surface antigen quantification: why and how to use it in 2011-a core group report[J]. Journal of Hepatology,2011,55(5) : 1121-1131.
  • 5De Gascun CF,Fraher M, Crean M, et al. The impor- tance of being earnest.- Following up a low level hepa- titis B surface antigen (HBsAg) result[J]. Journal of Clinical Virology,2010,49(2) : 79-81.
  • 6Bamaga MS, Sobahy TM, Attar AA. Quantitative DNA analysis of very low-level hepatitis B viremic patients reporting to the gastroenterology clinic[J]. Saudi Med J,2011,32(2) :135-140.
  • 7Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infeetion[J]. Clin Res Hepatol Gastroenterol, 2011,35 (8/9) : 554- 559.
  • 8Marangoni A, Sambri V, Accardo S, et al. Evaluation of LIAISON treponema screen,a novel recombinant antigen- based chemiluminescence immunoassay for laboratory di- agnosis of syphilis[J]. Clin Diagn Lab Immunol, 2005,12 (10):1231-1234.
  • 9Shinkai N, Matsuura K, Sugauchi F,et al. Application of a newly developed high-sensitivity HBsAg chemiIumines- cent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance[J]. J Clin Microbiol, 2013,51 ( 11 ) :3484-3491.
  • 10Krawczyk A, Hintze C, Ackermann J, et al. Clinical per- formance of the novel DiaSorin LIAISON( ) XL mur- ex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays [J]. J Clin Virol, 2014,59 (1) : 44-49.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部